Anderson, H.V.

ifn -α patient ifn -γ infection response expression therapy induction disease interferon treatment ifn -α therapy immunol mycobacterial deficiency mycobacteria ifn -γr deficiency ifn -α injection ifn -γr gene expression macrophage effect avium cytokine mycobacterium receptor abscessu control culture stat 1 mycobacterial disease blood ifn γr deficiency stimulation ifn -α treatment j clin immunol tuberculosis protein mycobacterial infections j immunol level month activation production holland injection lymph liver function lesion lymphadenopathy interferon-gamma antimycobacterial subcutaneously improvement 2 years ifn -γ response immunity pathway antimycobacterial therapy head wound cxcl 11 cxcl 10 van dissel jt stat 1 homodimers type i il -1β production mycobacterium avium result isg 15 deficiency type ii interferons vivo mrna expression target ifn -γ therapy ifn -α2b 3 abscessus infection antimycobacterial regimen holland sm tnf -α monocyte